Sepsis: Difference between revisions
From IDWiki
(Imported from text file) |
(added ddx) |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
== |
==Definition== |
||
* |
*Life-threatening organ dysfunction caused by a dysregulated host response to infection |
||
* |
*Characterized by an acute change in SOFA score ≥ 2 points in the context of infection |
||
** |
**Mortality 10% |
||
* |
*Septic shock is sepsis with profound underlying circulatory and metabolic derangements |
||
** |
**Characterized by both '''lactate >2mmol/L and pressors''' to keep MAP ≥65 despite fluids |
||
** |
**Mortality 35-54% |
||
== Non-Infectious Differential Diagnosis == |
|||
![](SOFA Table.png) |
|||
* [[Acute myocardial infarction]] |
|||
⚫ | |||
* [[Pulmonary embolism]] |
|||
* [[Anaphylaxis]] |
|||
* [[Pancreatitis]] |
|||
* [[Diabetic ketoacidosis]] |
|||
* [[Hypovolemia]] |
|||
* [[Small bowel obstruction]] |
|||
* Medication intoxication or adverse reaction |
|||
* [[Adrenal insufficiency]] |
|||
* Severe [[anemia]] |
|||
* [[Heart failure]] |
|||
* [[Inflammatory bowel disease]] |
|||
* [[Systemic lupus erythematosus]] |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
*** Passive leg raise |
|||
⚫ | |||
⚫ | |||
*** |
***Passive leg raise |
||
⚫ | |||
⚫ | |||
***SV on PoCUS |
|||
**** Intubated/ventilated: distensibility index >15-20% |
|||
⚫ | |||
⚫ | |||
**** |
****Intubated/ventilated: distensibility index >15-20% |
||
⚫ | |||
⚫ | |||
****Not intubated: IVC <2cm and variation >50% |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
**** Slight improvement in mortality seen in [https://dx.doi.org/10.1056/NEJMoa1705716 one trial] |
|||
⚫ | |||
⚫ | |||
**** [https://dx.doi.org/10. |
****Slight improvement in mortality seen in [https://dx.doi.org/10.1056/NEJMoa1705716 one trial] |
||
⚫ | |||
****[https://dx.doi.org/10.1136/bmj.k3284 A systematic review from BMJ] |
|||
[[Category:Critical care]] |
[[Category:Critical care]] |
Latest revision as of 01:25, 12 August 2020
Definition
- Life-threatening organ dysfunction caused by a dysregulated host response to infection
- Characterized by an acute change in SOFA score ≥ 2 points in the context of infection
- Mortality 10%
- Septic shock is sepsis with profound underlying circulatory and metabolic derangements
- Characterized by both lactate >2mmol/L and pressors to keep MAP ≥65 despite fluids
- Mortality 35-54%
Non-Infectious Differential Diagnosis
- Acute myocardial infarction
- Pulmonary embolism
- Anaphylaxis
- Pancreatitis
- Diabetic ketoacidosis
- Hypovolemia
- Small bowel obstruction
- Medication intoxication or adverse reaction
- Adrenal insufficiency
- Severe anemia
- Heart failure
- Inflammatory bowel disease
- Systemic lupus erythematosus
Management
- Based on the Surviving Sepsis Campaign
- Hour-1 Bundle: to be started within 1 hour of triage
- Measure lactate, repeat within 2-4h if >2mmol/L
- Obtain blood cultures, before antibiotics if possible
- Provide broad-spectrum antibiotics
- Each hour delay increases mortality by 7.6%
- Inappropriate initial antibiotics double mortality from 30% to 60%
- Administer 30ml/kg crystalloid for hypotension or lactate ≥4 mmol/L
- Vasopressors if needed to maintain MAP ≥65 mmHg
- Norepinephrine then vasopressin
- After the hour-1 bundle
- Don't forget to reassess lactate
- Assess fluid responsiveness and bolus more fluids, if indicated
- Passive leg raise
- Pulse pressure variation
- SV on PoCUS
- IVC
- Intubated/ventilated: distensibility index >15-20%
- Intubated/breathing: cannot use
- Not intubated: IVC <2cm and variation >50%
- Add pressors, if needed to maintain MAP ≥65mmHg
- Norepinephrine first, at a dose of 0.03-3mcg/kg/min
- Vasopressin or epinephrine second
- Dobutamine third
- Add steroids, if indicated
- No steroids if they have responded to fluids and pressors
- If still unwell, give hydrocortisone 200mg IV total daily dose
- Slight improvement in mortality seen in one trial
- May be beneficial in shock
- A systematic review from BMJ